INTRODUCTION
This document updates and replaces CDC's previously published "Guideline for Prevention of Nosocomial Pneumonia 1983;11:230-44). This revised guideline is designed to reduce the incidence of nosocomial pneumonia and is intended hospitals; the information may not be applicable in long-term-care facilities because of the unique characteristics of su This revised guideline addresses common problems encountered by infection-control practitioners regarding the preven bacterial pneumonia in mechanically ventilated and/or critically ill patients, care of respiratory-therapy devices, preven respiratory syncytial virus {RSV} and influenza infections) have been expanded and updated. New sections on Legion infection caused by Mycobacterium tuberculosis is not addressed in this document; CDC published such recommendat Several large studies have examined the potential risk factors for nosocomially acquired bacterial pneumonia (Table_2 can be grouped into the following general categories: a. host factors (e.g., extremes of age and severe underlying conditions, including immunosuppression); b) factors th of antimicrobials, admission to an ICU, underlying chronic lung disease, or coma); c) conditions favoring aspira conditions requiring prolonged use of mechanical ventilatory support with potential exposure to contaminated re that impede adequate pulmonary toilet (e.g., undergoing surgical procedures that involve the head, neck, thorax,
A. Oropharyngeal, Tracheal, and Gastric Colonization
The association between colonization of the oropharynx (88, 137) , trachea (138) , or stomach (110, 111, 117, 123 ) a using either prophylactic local application of antimicrobial agent(s) (139,140) or local bacterial interference (141 could eradicate common gram-negative pathogens from the upper respiratory tract (138) , superinfection occurre interference {with alpha-hemolytic streptococci}) has been used successfully by some investigators to prevent o method for general usage has not been evaluated.
In many studies, the administration of antacids and H-2 blockers for prevention of stress bleeding in critically ill overgrowth (34, 112, 113, 118, 122, 123, (145) (146) (147) . Sucralfate, a cytoprotective agent that has little effect on gastric antacids and H-2 blockers (148-150). The results of clinical trials comparing the risk for pneumonia in patients r (112, 118, 147, 148, (151) (152) (153) . In most randomized trials, ICU patients receiving mechanically assisted ventilation pH, high bacterial counts in the gastric fluid, and increased risk for pneumonia in comparison with patients treate early-onset pneumonia (i.e., onset occurring less than or equal to 4 days after intubation) did not differ between p of 69 treated with antacids, and 21% of 68 treated with an H-2 blocker (147). Conversely, a meta-analysis of dat indicate a strong association between nosocomial pneumonia and drugs that increase gastric pH. Additional stud are being conducted to compare the efficacy of sucralfate and ranitidine.
Selective decontamination of the digestive tract (SDD) is another strategy designed to prevent bacterial coloniza aimed at preventing oropharyngeal and gastric colonization with aerobic gram-negative bacilli and Candida sp. w administered nonabsorbable antibiotic agents, such as polymyxin and an aminoglycoside (either tobramycin, gen either amphotericin B or nystatin. The local antimicrobial preparation is applied as a paste to the oropharynx and a systemic (intravenous) antimicrobial (e.g., cefotaxime or trimethoprim) is administered to the patient.
Although most studies (155-158,160-167,169,170,175-177), including two meta-analyses (171,178), have demo been difficult to assess because they have differed in design and study population and many have had short follo criteria; bronchoscopy with BAL or PSB was used in only a few studies (159, 162, 173, (175) (176) (177) 179) .
Two recently published reports of large, double-blind, placebo-controlled trials demonstrated no benefit from SD gram-negative bacillary pneumonia decreased significantly after SDD, but this decrease was not accompanied by between patients randomly assigned to SDD or placebo treatment conditions; however, both patient groups also
Although an earlier meta-analysis indicated a trend toward decreased mortality in patients administered SDD (17 mortality, as well as the high cost of using SDD to prevent nosocomial pneumonia or death resulting from nosoc nine patients} would have to be administered SDD; to prevent one death, 23 patients {range: 13-39 patients}) (1 positive bacteria and other antibiotic-resistant nosocomial pathogens are public health concerns (156,158, 159,1 nosocomial pneumonia in ICU patients. SDD may be ultimately useful for specific subsets of ICU patients, such increased intragastric volume and pressure (70, 117, 183) .
Although prevention of pneumonia in such patients may be difficult, methods that make regurgitation less likely withholding enteral feeding if the residual volume in the stomach is large or if bowel sounds are not heard upon been obtained by a) administering enteral nutrition intermittently in small boluses rather than continuously (70,1 stomach (e.g., in the jejunum) (199, 200) .
C. Mechanically Assisted Ventilation and Endotracheal Intubation
Patients receiving continuous, mechanically assisted ventilation have 6-21 times the risk for acquiring nosocomi indicated that the risk for developing ventilator-associated pneumonia increased by 1% per day (5) . This increase endotracheal tube into the trachea during intubation, as well as to depressed host defenses secondary to the patie tube over time and form a glycocalyx (i.e., a biofilm) that protects the bacteria from the action of antimicrobial a dislodged by ventilation flow, tube manipulation, or suctioning and subsequently embolize into the lower respira and using aseptic techniques to reduce cross-contamination to patients from contaminated respiratory therapy eq pneumonia in patients receiving mechanically assisted ventilation.
The risk for pneumonia also is increased by the direct access of bacteria to the lower respiratory tract, which ofte above the cuff to enter the trachea (206). In one study, the occurrence of nosocomial pneumonia was delayed and drainage (i.e., by suctioning) of secretions in the space above the endotracheal tube cuff and below the glottis (20
D. Cross-Colonization Via Hands of HCWs
Pathogens that cause nosocomial pneumonia (e.g., gram-negative bacilli and S. aureus) are ubiquitous in hospita patients frequently occurs via an attending HCW's hands that have become contaminated or transiently colonized ventilator circuit or endotracheal tubes increase the opportunity for cross-contamination (215,216). The risk for c when appropriate (65) and by eliminating pathogens from the hands of HCWs (65, 215, (217) (218) (219) .
In theory, adequate handwashing is an effective way of removing transient bacteria from the hands (218,219); ho 223). For this reason, the routine use of gloves has been advocated to help prevent cross-contamination (224,225 incidence of nosocomial RSV infection (226) and other infections acquired in ICUs (227). However, nosocomia gloves after having contact with one patient and before providing care to another (229,230). In addition, gloved h
E. Contamination of Devices Used on the Respiratory Tract
Devices used on the respiratory tract for respiratory therapy (e.g., nebulizers), diagnostic examination (e.g., bron for infectious microorganisms (65, (232) (233) (234) (235) (236) In some hospitals, a tap-water rinse followed by complete drying is achieved after a tap-water rinse, the risk for nosocomial pneumonia associated with the use o HCWs after washing, and air drying also reduces contamination of gastrointestinal endoscopes (274-276). Howe nebulizers, and bronchoscopes) are difficult to dry, and the degree of dryness of a device is difficult to assess (26 drying) reusable semicritical respiratory devices after their disinfection or between their uses on the same patient 1. Mechanical Ventilators, Breathing Circuits, Humidifiers, Heat-Moisture Exchangers, and In-Line Nebuliz a. Mechanical ventilators. The internal machinery of mechanical ventilators used for respiratory therap routine sterilization or high-level disinfection of the internal machinery is considered unnecessary. U advocated previously (279,280). Filters interposed between the machinery and the main breathing ci machine by the patient; however, these filters also might alter the functional specifications of the bre expiratory-phase tubing of the mechanical-ventilator circuit may help prevent cross-contamination preventing nosocomial pneumonia needs further evaluation.
b. Breathing circuits, humidifiers, and heat-moisture exchangers. In the United States, most hospitals u (132, 283) or no aerosols, respectively, for humidification. Thus, these devices probably do not pose heated to temperatures that reduce or eliminate bacterial pathogens (283,284). Sterile water, howeve microorganisms, such as Legionella sp., that are more heat-resistant than other bacteria (252,271).
The potential risk for pneumonia in patients using mechanical ventilators that have heated bubble-th the ventilator circuit as a result of the difference in the temperatures of the inspiratory-phase gas and condensate can rapidly become contaminated, usually with bacteria that originate in the patient's oro within 2 hours, and 80% within 24 hours, after initiation of mechanical ventilation (286). Spillage o procedures in which the tubing is moved (e.g., for suctioning, adjusting the ventilator setting, or feed many hospitals, HCWs are trained to prevent such spillage and to drain the fluid periodically. Micro hands of HCWs handling the fluid, especially if the HCW neglects washing hands after handling the
The role of ventilator-tubing changes in preventing pneumonia in patients using mechanical ventilat mechanical ventilator circuits with humidifiers have indicated that neither the rate of bacterial conta tubing was changed every 24 hours rather than every 8 or 16 hours (287). A later study indicated tha increase in contamination of the inspiratory-phase gas or tubing of the ventilator circuits (288). In ad changed every 48 hours rather than every 24 hours (288). More recent reports suggest that the risk f Another study indicated that the risk for pneumonia was not significantly higher when the circuits w when the circuits were changed every 48 hours (11 {31%} of 35 patients) (289).
These findings indicate that the recommended daily change in ventilator circuits may be extended to savings for U.S. hospitals by reducing the number of circuits used and the amount of personnel time left unchanged on a patient has not been determined.
Condensate formation in the inspiratory-phase tubing of a ventilator breathing circuit can be decreas phase tubing. However, in one report, three cases of endotracheal-or tracheostomy-tube blockage b gas that resulted from the elevation of the gas temperature (290). Until additional information regard mechanical ventilation should be aware of the advantages and potential complications associated wi
Condensate formation can be eliminated by using a heat-moisture exchanger (HME) or a hygroscop exhaled by the patient and eliminates the need for a humidifier. In the absence of a humidifier, no co of the tubing is prevented, and the need to change the tubing on a periodic basis is obviated (216). S unknown. HMEs can increase the dead space (i.e., the area of the lung in which air is not exchanged sputum and blockage of the tracheobronchial tree (297). Although recently developed HMEs that ha additional studies are needed to determine whether the incidence of pneumonia is decreased (299-30 c. Small-volume ("in-line") medication nebulizers. Small-volume medication nebulizers that are insert devices become contaminated by condensate in the inspiratory tubing of the breathing circuit, they c endotracheal tube and bypasses many of the normal host defenses against infection (286).
2. Large-Volume Nebulizers. Nebulizers with large-volume (greater than 500 cc) reservoirs, including those room-air humidifiers, pose the greatest risk for pneumonia to patients, probably because of the large amou hands of HCWs, unsterile humidification fluid, or inadequate sterilization or disinfection between uses (12 sufficiently large numbers within 24 hours to pose a risk for infection in patients who receive inhalation th eliminate vegetative bacteria from their reservoirs and make them safe for patient use (260). However, unl evidence of clinical benefits from their use in hospitals is lacking, and the potential cost of daily sterilizati 3. Hand-Held Small-Volume Medication Nebulizers. Small-volume medication nebulizers used to administe nebulizers have been associated with nosocomial pneumonia, including Legionnaires disease, resulting fro water used for rinsing and filling the reservoir (258). Reusable resuscitation bags are particularly difficult to clean and dry between uses; microorganisms in sec the patient on whom the bag is used; in addition, contaminating microorganisms might be transmitted from have been associated with outbreaks of gram-negative respiratory tract colonization and pneumonia resulti require either sterilization or high-level disinfection between uses on different patients. Education of physi these devices is essential.
5. Anesthesia Equipment. The contributory role of anesthesia equipment in outbreaks of nosocomial pneumo disinfection/sterilization of reusable anesthesia-equipment components that could become contaminated w a. Anesthesia machine. The internal components of anesthesia machines, which include the gas source important source of bacterial contamination of inhaled gases (316). Thus, routine sterilization or hig b. Breathing system or patient circuit. The breathing system or patient circuit (including the tracheal tu anesthesia ventilator bellows and tubing, humidifier, adjustable pressure-limiting valve, and other de become contaminated with microorganisms that might originate from the patient's oropharynx or tra disinfection or sterilization) of the components of the breathing system have been published (317,31 membranes (e.g., face mask or tracheal tube) or become readily contaminated with the patient's resp and subjected to high-level disinfection or sterilization between patients. The other parts of the breat schedule of reprocessing has not been firmly determined (319), are changed, cleaned, and sterilized (317,318) and/or the manufacturers' instructions.
Using high-efficiency bacterial filters at various positions in the patient circuit (e.g., at the y-piece o shown to decrease contamination of the circuit (321-323). However, the use of bacterial filters to pr analysis (324-326).
6. Pulmonary Function Testing Apparatus.
a. Internal parts of pulmonary function testing apparatus. The internal parts of pulmonary function test gas (327). However, because of concern about possible carry-over of bacterial aerosols from an infe that remove exhaled bacteria) between the patient and the testing equipment has been advocated (24 nosocomial pneumonia (330).
b. Tubing, rebreathing valves, and mouthpieces. Tubing, connectors, rebreathing valves, and mouthpie apparatus. Thus, these items should be cleaned and subjected to high-level disinfection or sterilizatio
F. Thoracoabdominal Surgical Procedures
Certain patients are at high risk for developing postoperative pulmonary complications, including pneumonia. Th obstructive pulmonary disease (331-334). Abnormal results from pulmonary function tests (especially decreased intubation, or protein depletion that can cause respiratory-muscle weakness are also risk factors (62, 68, 136) . Pat swallowing and respiratory clearance mechanisms as a result of instrumentation of the respiratory tract, anesthes abdominal surgery usually have diaphragmatic dysfunction that results in decreased functional residual capacity
Interventions aimed at reducing the postoperative patient's risk for pneumonia have been developed (339). These continuous positive airway pressure by face mask (339-349). Studies evaluating the relative efficacy of these mo variables assessed, patient populations studied, and study design (339, 341, 342, (348) (349) (350) Underlying disease and advanced age are risk factors not only for acquiring Legionnaires disease but also for dy through 1989, immunosuppression, advanced age, end-stage renal disease, cancer, and nosocomial acquisition o among 803 persons who had nosocomially acquired cases, compared with 20% among 2,721 persons who had co underlying disease in hospitalized patients.
II. Diagnosis
The clinical spectrum of disease caused by Legionella sp. is broad and ranges from asymptomatic infection to ra radiographically from pneumonia caused by other agents (407,408), and evidence of infection with other respira
The diagnosis of legionellosis may be confirmed by any one of the following: culture isolation of Legionella from secretions or tissue by immunofluorescent microscopy, or, for legionellosis caused by Legionella pneumophila s observation of a four-fold rise in L. pneumophila serogroup-1 antibody titer to greater than or equal to 1:128 in p (IFA) test (412,413). A single elevated antibody titer does not confirm a case of Legionnaires disease because IF
Because the above tests complement each other, performing each test when Legionnaires disease is suspected in tests is 100% sensitive, the diagnosis of legionellosis is not excluded even if one or more of the tests are negative respiratory tract specimen (419,420).
Modes of Transmission
Inhalation of aerosols of water contaminated with Legionella sp. might be the primary mechanism by which these orga to be infected through exposure to contaminated aerosols generated by cooling towers, showers, faucets, respiratory th contaminated potable water or pharyngeal colonizers was proposed as the mode of transmission to certain patients (425
IV. Definition of Nosocomial Legionnaires Disease
The incubation period for Legionnaires disease is usually 2-10 days (431); thus, for the purposes of this document and patient who has been hospitalized continuously for greater than or equal to 10 days before the onset of illness is consid occurs 2-9 days after hospital admission is a possible case of the disease.
V. Prevention and Control Measures

A. Prevention of Legionnaires Disease in Hospitals with No Identified Cases (Primary Prevention)
Prevention strategies in health-care facilities in which no cases of nosocomial legionellosis have been identified facility, the resources available for implementing prevention strategies, and state and local regulations.
At least two strategies are practiced with regard to the most appropriate and cost-effective means of preventing n illness have been detected. However, a study comparing the cost-benefit ratios of these strategies has not been co
The first approach is based on periodic, routine culturing of water samples from the hospital's potable water syst samples obtained are culture-positive for Legionella sp., the hospital's potable water system is decontaminated (4 microbiology department so that active surveillance for cases can be implemented (433,434). This approach is b present in the potable water system, and, conversely, if Legionella sp. are cultured from the water, cases of noso are informed that the potable water system of the hospital is culture-positive for Legionella sp., they are more inc approach in hospitals in which no cases of nosocomial legionellosis have occurred is that routinely culturing a lim for all patients who have nosocomial pneumonia.
The main argument against this approach is that, in the absence of cases, the relationship between the results of w present in water systems of buildings (436), often without being associated with known cases of disease (271,38 colonized with Legionella sp., and 26% were colonized at greater than 30% of sites sampled; however, cases of which active surveillance for legionellosis and environmental culturing for Legionella sp. were done, no cases of from the ward were culture-positive for L. pneumophila serogroup 1 (385). Interpretation of the results of routin single water system and by fluctuations in the concentration of Legionella sp. at the same site (439,440). In addit other than the presence or concentration of organisms; these factors include the degree to which contaminated w host, the susceptibility of the host, and the virulence properties of the contaminating strain (441-443). Thus, data forming units detected in samples from the hospital environment. By routinely culturing water samples, many ho identified. Because of this problem, routine monitoring of water from the hospital's potable water system and fro
The second approach to preventing and controlling nosocomial legionellosis involves a) maintaining a high inde who have nosocomial pneumonia and who are at high risk for developing the disease and dying from the infectio of one case of definite or two cases of possible nosocomial Legionnaires disease, and c) routinely maintaining co Measures used in hospitals in which cases of nosocomial legionellosis have been identified include either a) rout chlorination of heated water to achieve 1-2 mg/L of free residual chlorine at the tap, especially in areas where im benefit ratio of such measures in hospitals in which no cases of legionellosis have been identified needs addition
B. Prevention of Legionnaires Disease in Hospitals with Identified Cases (Secondary Prevention)
The indications for a full-scale environmental investigation to search for and subsequently decontaminate identif probably differ depending on the hospital. In hospitals in which as few as one to three nosocomial cases are iden frequently identified numerous additional cases (403,422,425,447). This finding suggests the need for a low thre legionellosis. However, when developing a strategy for responding to such an identification, infection-control pe Legionella sp. infection at their particular hospital.
An epidemiologic investigation conducted to determine the source of Legionella sp. involves several important s should be initiated to identify all recent or ongoing cases of legionellosis. Third, potential risk factors for infectio should be identified by creating a line listing of cases, analyzing the collected information (by time, place, and p collected from environmental sources implicated by the epidemiologic investigation and from other potential sou environmental samples should be conducted (427,450-452). This last step can be crucial in supporting epidemiol
In some hospitals in which the heated-water system was identified as the source of the organism, the system was outlet of the hot-water system for at least 5 minutes with water at greater than or equal to 65 C) and hyperchlorin mg/L of free residual chlorine) (449, 454-456). After either of these procedures, most hospitals either a) maintain water to achieve 1-2 mg/L of free residual chlorine at the tap (385,428,439,446-449). Additional measures (e.g., showerheads) may be required because scale and sediment might accumulate in this equipment and protect organ and eradicating legionellae in water systems (e.g., treating water with ozone, ultraviolet light, or heavy metal ion However, additional data are needed regarding the efficacy of these methods before they can be considered stand previously (463).
Additional preventive measures have been used to protect severely immunocompromised patients. At one hospit sterile water was used for drinking or flushing nasogastric tubes (429). In another hospital, a combined approach hyperchlorination of the water supply to the bone-marrow transplant unit was used to decrease the incidence of L The decision to search for hospital environmental sources of Legionella sp. and the choice of procedures to use t hospital. Furthermore, decision makers should consider a) the high cost of an environmental investigation and of b) the differential risk, based on host factors, for acquiring nosocomial legionellosis and of having severe and fat ASPERGILLOSIS I. Epidemiology Aspergillus sp. are ubiquitous fungi that commonly occur in soil, water, and decaying vegetation. Aspergillus sp hospital renovation and construction, horizontal surfaces, food, and ornamental plants (466).
Aspergillus fumigatus and Aspergillus flavus are the most frequently isolated Aspergillus sp. in patients who hav increasingly as a cause of severe illness and mortality in highly immunocompromised patients (e.g., patients und hematologic and other malignant neoplasms) (468-472).
The most important nosocomial infection caused by Aspergillus sp. is pneumonia (473,474). Hospital outbreaks bone-marrow transplant units (473-480). Although invasive aspergillosis has been reported in recipients of solid these patients has been lower than in recipients of bone-marrow transplants, probably because granulocytopenia transplant recipients, has decreased with the introduction of cyclosporine (483,486). The efficacy of infection-co in preventing aspergillosis in solid-organ transplant recipients has not been well evaluated (483, 484, 486, 487 504), and syste infection (505-507). Antigen-based serologic assays are being developed in an attempt to allow for the rapid and specif been determined (508,509).
IV. Risk Factors and Control Measures
The primary risk factor for invasive aspergillosis is severe and prolonged granulocytopenia, both disease-and therapygranulocytopenia, they probably constitute the population at highest risk for developing invasive aspergillosis (490,511 than 1,000 polymorphonuclears/uL) is associated with the type of graft they receive. Although both autologous and all transplant procedure, acute or chronic graft-versus-host disease also could develop in allogeneic-transplant recipients.
(which often includes high doses of corticosteroids, cyclosporine, and other immunosuppressive agents) might result in infection in bone-marrow-transplant recipients, infection-control personnel should consider exposures of the patient to discharge, patients (especially allogeneic-transplant recipients) might continue to manifest severe granulocytopenia and address the problem of invasive aspergillosis in bone-marrow-transplant recipients, various studies are in progress to e b) eliminating or suppressing respiratory fungal colonization of the upper respiratory tract. These methods include, resp amphotericin B or oral or systemic antifungal drug prophylaxis (466,512-515). For solid-organ transplant recipients, ri transplant recipients, risk factors for invasive infection with Aspergillus sp. included preoperative and postoperative re
The presence of aspergilli in the hospital environment is the most important extrinsic risk factor for opportunistic invas renovation activities in and around hospitals markedly increase the airborne Aspergillus sp. spore counts in such hospit immunosuppressed patients also has been associated with other hospital environmental reservoirs. Such reservoirs incl A single case of nosocomial Aspergillus sp. pneumonia is often difficult to link to a specific environmental exposure. H retrospective review of microbiologic, histopathologic, and postmortem records; notification of clinicians caring for hi When additional cases are detected, the likelihood is increased that a hospital environmental source of Aspergillus sp. construction activities and/or fungal contamination of hospital air-handling systems as major sources for outbreaks (47 endonuclease profiling, which is now available for A. fumigatus {526}) may substantially aid in identifying the source Outbreaks of invasive aspergillosis reinforce the importance of maintaining an environment as free as possible of Aspe services in many large hospitals --particularly bone-marrow transplant services --have installed "protected environme vigilance during hospital construction and routine maintenance of hospital air-filtration and ventilation systems to prev
Although the exact configuration and specifications of the protected environments might differ between hospitals, such incoming air by using central or point-of-use high-efficiency particulate air (HEPA) filters that are capable of removin from intake on one side of the room, across the patient, and out through the exhaust on the opposite side of the room); room-air changes (range: 15 to greater than 400 per hour), although air-change rates at the higher levels might pose pro environment is a room with laminar airflow. Such an environment consists of a bank of HEPA filters along an entire w velocity (90 plus or minus 20 feet/minute), forcing the air to move in a laminar, or at least unidirectional, pattern (535) air changes per hour) are achieved (473,527). The net effects are essentially sterile air in the room, minimal air turbule
The laminar-airflow system is effective in decreasing or eliminating the risk for nosocomial aspergillosis in high-risk p alternative systems with lower air-change rates (i.e., 10-15 air changes per hour) have been used in some hospitals (529 airflow rooms in eliminating Aspergillus sp. spores and preventing nosocomial aspergillosis are limited. One hospital t that cases of nosocomial aspergillosis had occurred in patients housed in these rooms, although this rate was low (i.e., cultured from the room air, suggesting that the patients were probably exposed to fungal spores when they were allowe Copper-8-quinolinolate was used on environmental surfaces contaminated with Aspergillus sp. to control one reported constructed hospital to help decrease the environmental spore burden (530); however, its general applicability has not b VIRAL PNEUMONIAS Viruses can be an important and often unappreciated cause of nosocomial pneumonia (538-540). In one prospective stu infections (539). Although the early diagnosis and treatment of viral pneumonia infections have been possible in recen sometimes fatal viral pneumonia (538,545-552). These data and reports of well-documented outbreaks involving nosoc instituted.
Nosocomial respiratory viral infections a) usually follow community outbreaks that occur during a particular period ev persons (547,548,554,562-564), and d) have exogenous sources. A number of viruses --including adenoviruses, influe cause nosocomial pneumonia (548,555,556,565-571,572); however, adenoviruses, influenza viruses, parainfluenza viru (573).
Influenza and RSV infections contribute substantially to the morbidity and mortality associated with viral pneumonia, section concerning viral pneumonias focuses on the principles of, and approaches to, the control of these two types of i viral pathogens were published previously (224).
RSV INFECTION I. Epidemiology
RSV infection is most common during infancy and early childhood, but it can also occur in adults (562,565,574, life-threatening pneumonia and bronchiolitis have occurred in immunocompromised patients, the elderly, and ch Recent surveillance of 10 U.S. hospital laboratories in which cultures for RSV are performed suggests that comm months and are associated with an increased number of hospitalizations and deaths among infants and young chi time of hospital admission are often reservoirs for RSV (553,555).
II. Diagnosis
The clinical characteristics of RSV infection, especially in neonates, are often indistinguishable from those of oth standard for diagnosis. Rapid antigen-detection kits that use direct immunofluorescence or enzyme-linked immu infected patients depends on the sensitivity and specificity of the test. The reported sensitivity and specificity of (579-582). In general, once laboratory-confirmed cases of RSV infection are identified in a hospital, a presumpti may be acceptable for infection-control purposes.
Modes of Transmission
RSV is present in large numbers in the respiratory secretions of symptomatic persons infected with the virus, and it can RSV-contaminated hands or fomites (553,583,584). The portal of entry is usually the conjunctiva or the nasal mucosa The wearing of gloves and gowns has been associated with decreased incidence of nosocomial RSV (226). The wearin comply with handwashing and other precautions and deter them from touching their eyes or nose. However, the benefi patient or with contaminated fomites and if hands are not washed adequately after glove removal (229). The wearing o has been successful in preventing infection (226). In addition, the use of eye-nose goggles rather than masks has protec to wear (593,597).
Additional measures may be indicated to control ongoing nosocomial transmission of RSV or to prevent transmission t cardiac, pulmonary, or immune systems are compromised). The following additional control measures have been used with or without preadmission screening by rapid laboratory diagnostic tests; b) cohorting HCWs; c) excluding HCWs w risk for severe or fatal RSV infection (e.g., infants); d) limiting visitors; and e) postponing admission of patients at high of these measures has not been determined, their use for controlling RSV outbreaks seems prudent.
INFLUENZA I. Epidemiology
Pneumonia that occurs in patients who have influenza can be caused by the influenza virus, a secondary bacteria person but is more common in infants and young children, in persons greater than 65 years of age, and in person underlying heart or lung disease) (575,601-603).
Influenza typically occurs on a seasonal basis during December-April; during this period, peak influenza activity community affected by an influenza epidemic; these outbreaks are often characterized by abrupt onset and rapid homes; however, hospital outbreaks in pediatric and chronic-care wards and in medical and neonatal intensive-c Influenza is believed to be spread from person to person by a) direct inhalation of droplet nuclei or small-particle respiratory tract of a person during close contact with an infected person (613-616). The extent to which transmi contact is not the primary mode of transmission (617).
The most important reservoirs of influenza virus are infected persons. Although the period of greatest communic and for greater than or equal to 7 days afterward (556,604, 618).
II. Diagnosis
Influenza is clinically indistinguishable from other febrile respiratory illnesses; however, during outbreaks with l have similar manifestations (619). Historically, diagnosis of influenza was made by virus isolation from nasopha similar to culture in sensitivity and specificity now enable early diagnosis and treatment of cases and provide a b
Prevention and Control of Influenza
The most effective measure for reducing the impact of influenza is the vaccination of persons at high risk for complica persons 6 months-18 years of age who are receiving long-term aspirin therapy and persons who either a) are greater tha the pulmonary or cardiovascular systems, diabetes mellitus, renal dysfunction, hemoglobinopathies, or immunosuppres also may be at high risk for complications resulting from influenza. When high vaccination rates are achieved in closed 632-634) . Thes short-term prophylaxis for high-risk persons after late vaccination; b) as prophylaxis for persons for whom vaccination protective levels of antibody in response to vaccination; d) as prophylaxis for unvaccinated HCWs who provide care to until immunity develops after vaccination; and e) as prophylaxis when vaccine strains do not closely match the epidem Amantadine has been available in the United States for many years; rimantadine has been approved for use since 1993 changes in the virus that might reduce vaccine efficacy do not alter the effectiveness of amantadine or rimantadine. Bo virus (632,635). In addition, they can reduce the severity and duration of illness caused by influenza A virus if adminis spread of influenza type A if they are administered to all or most patients when influenza type A illnesses begin in a fa Compared with rimantadine, amantadine has been associated with a higher incidence of adverse central nervous system changes, and lightheadedness). These symptoms have been reported in 5%-10% of healthy young adults receiving 200 addition, dizziness and ataxia occur more frequently among persons in this age group than among younger persons (64 such as persons greater than or equal to 65 years of age and/or those who have renal insufficiency. The drug package in these drugs. Guidelines for the use of amantadine and rimantadine and considerations for the selection of these drugs w
The emergence of amantadine-and rimantadine-resistant strains of influenza A virus has been observed in persons who transmitting resistant viral strains to contacts of persons receiving amantadine or rimantadine for treatment (643,644), treatment and for 2 days after discontinuing treatment (644,645). This is particularly important if the contacts are uninf
The primary focus of efforts to prevent and control nosocomial influenza is the vaccination of high-risk patients and H rimantadine as an adjunct to vaccination in the prevention and control of nosocomial influenza is based partially on res of influenza type A occur in a hospital, and antiviral prophylaxis of high-risk persons and/or treatment of cases is unde to reduce transmission (609,638,631).
Measures other than vaccination and chemoprophylaxis have been recommended for controlling nosocomial influenza following procedures have been recommended: observing contact-isolation precautions, placing patients who have sym wearing a mask when entering a room in which a person who has suspected or confirmed influenza is housed (224). H also have been recommended; however, the exact role of these measures in preventing influenza transmission has not b efficacy of placing infected persons in rooms that have negative air pressure in relation to their immediate environmen that occur during a community epidemic of influenza because many HCWs and newly admitted patients could be infec persons in rooms that have special ventilation. Although the effectiveness of the following measures has not been deter elimination of elective admissions, both medical and surgical; b) restriction of cardiovascular and pulmonary surgery; restriction of HCWs who have an acute respiratory illness from the workplace (649).
INTRODUCTION
These recommendations are presented in the following order based on the etiology of the infection: bacterial pneumon pneumonia (i.e., RSV and influenza infections). Each topic is subdivided according to the following general approache This requires that water in calorifiers (water heaters) be maintained at greater than or equal to 60 C. In the United King mandated, installation of blending or mixing valves at or near taps to reduce the water temperature to less than or equa visitors, and HCWs (446). However, Legionella sp. can multiply even in short segments of pipe containing water at thi likelihood of water stagnation and cooling (449,723). Insulation of plumbing to ensure delivery of cold (less than 20 C multiplication (391). Both "dead legs" and "capped spurs" * within the plumbing system provide areas of stagnation an to be removed to prevent colonization (724). Rubber fittings within plumbing systems have been associated with persis (725).
II. Continuous chlorination to maintain concentrations of free residual chlorine at 1-2 mg/L at the tap This requires the placement of flow-adjusted, continuous injectors of chlorine throughout the water distribution system results in system leaks and production of potentially carcinogenic trihalomethanes. However, when levels of free residu recommended by the Environmental Protection Agency (447,726,727).
A dead leg is a pipe, or spur, leading from the water recirculating system to an outlet that is used infrequently (i. spur is a pipe leading from the water recirculating system to an outlet that has been closed off (i.e., the spur has b wall is removed.
APPENDIX C Culturing Environmental Specimens for Legionella sp.
I. Recommended procedure for collecting and processing environmental specimens for Legionella sp. (728) A. Collect water (if possible, 1-L samples) in sterile, screw-top bottles, preferably containing sodium thiosulf any residual halogen biocide.)
B. Collect culture-swabs of the internal surfaces of faucets, aerators, and showerheads; in a sterile, screw-top taken from the same device from which the sample was obtained.
C. As soon as possible after collection, water samples and swabs should be transported to and processed in a room temperature but must be protected from temperature extremes. --------------------------------------------------------------------------------------------------------- 
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Host-related (persons aged >65 yrs)
Underlying ilness: --Chronic obstructive Perform incentive spirometry, positive end-expiratory pressure, or continuous pulmonary disease positive airway pressure by face mask.
--Immunosuppression Avoid exposure to potential nosocomial pathogens; decrease duration of immunosuppression (e.g., by administration of granulocyte macrophage colony stimulating factor ÿGMCSFº).
--Depressed consciousness Administer central nervious system depressants cautiously.
--Surgery (thoracic/ abdominal) Properly position patients; promote early ambulation; appropriately control pain.
Device-related Properly clean, sterilize or disinfect, and handle devices; remove devices as soon as the indication for their use ceases.
Endotracheal intubation and Gently suction secretions; place patient in semirecumbent position mechanical ventilation (i.e., 30 degrees-45 degrees head elevation); use nonalkalinizing gastric cytoprotective agent on patients at risk for stress bleeding; do not routinely change ventilator circuits more often than every 48 hours; drain and discard inspiratory-tubiing condensate, or use heatmoisture exchanger if indicated.
Nasogastric-tube (NGT) Routinely verify appropriate tube placement; promptly remove NGT when placement and enteral feeding no longer needed; drain residual; place patient in semirecumbent position as described as above.
Personnel-or procedure-related 
Environment related
Construction activity Remove granulocytopenic patients from vicinity of construction; if not already done, place severely granulocytopenic patients in a protected environment; make severely granulocytopenic patients wear a mask when they leave the protected environment.
Other environmental sources Routinely maintain hospital air-handling systems and rooms of of aspergilli immunosuppressed patients.
Respiratory syncytial virus infection (RSV)
Host-related Persons ages <2 yrs; Consider routine preadmission screening of high-risk patients for congenital pulmonary/cardiac severe RSV infection, followed by cohorting of patients and nursing disease; immunosuppression personnel during hospital outbreaks of RSV infection.
Personnel-or procedure-related
Cross-contaminated by hands Educate personnel; wash hands; wear gloves; wear a gown; during outbreaks, use private rooms or cohort patients and nursing personnel, and limit visitors.
Influenza
Host-related Persons ages >65 yrs; Vaccinate patients who are at high risk before the influenza season immunosuppresion begins each year; use amantadine or rimantadine for chemoprophylaxis during an outbreak.
Personnel-related
Infected personnel Before the influenza season each year, vaccinate personnel who provide care for high-risk patients; use amantadine or rimantadine for prohylaxis and treatment during an outbreak.
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